HomeComparePULT vs JNJ

PULT vs JNJ: Dividend Comparison 2026

PULT yields 4.68% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PULT wins by $7.2K in total portfolio value
10 years
PULT
PULT
● Live price
4.68%
Share price
$50.51
Annual div
$2.37
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.2K
Annual income
$631.95
Full PULT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PULT vs JNJ

📍 PULT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPULTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PULT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PULT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PULT
Annual income on $10K today (after 15% tax)
$397.99/yr
After 10yr DRIP, annual income (after tax)
$537.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $166.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PULT + JNJ for your $10,000?

PULT: 50%JNJ: 50%
100% JNJ50/50100% PULT
Portfolio after 10yr
$23.6K
Annual income
$729.87/yr
Blended yield
3.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PULT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PULT buys
0
JNJ buys
0
No recent congressional trades found for PULT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPULTJNJ
Forward yield4.68%3.36%
Annual dividend / share$2.37$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.2K$20.0K
Annual income after 10y$631.95$827.78
Total dividends collected$5.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PULT vs JNJ ($10,000, DRIP)

YearPULT PortfolioPULT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,168$468.23$10,676$355.77+$492.00PULT
2$12,439$488.72$11,407$389.39+$1.0KPULT
3$13,818$508.70$12,198$426.53+$1.6KPULT
4$15,314$528.15$13,056$467.62+$2.3KPULT
5$16,933$547.01$13,987$513.12+$2.9KPULT
6$18,683$565.28$14,998$563.56+$3.7KPULT
7$20,574$582.91$16,098$619.52+$4.5KPULT
8$22,614$599.91$17,295$681.69+$5.3KPULT
9$24,813$616.26$18,599$750.82+$6.2KPULT
10$27,182$631.95$20,022$827.78+$7.2KPULT

PULT vs JNJ: Complete Analysis 2026

PULTStock

The fund seeks as high a rate of current income that the fund's investment manager believes is consistent with preservation of capital and maintenance of liquidity. The fund invests in a diversified short duration portfolio of fixed-income securities comprised of investment-grade money market and other fixed-income securities, including U.S. dollar-denominated foreign securities of these types, with a focus on companies or issuers that the fund's investment manager believes meet relevant environmental, social or governance (ESG) criteria on a sector-specific basis.

Full PULT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PULT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PULT vs SCHDPULT vs JEPIPULT vs OPULT vs KOPULT vs MAINPULT vs ABBVPULT vs MRKPULT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.